Abstract
Toxoplasma gondii is one of the most prevalent parasites, causing toxoplasmosis in various warm-blooded animals, including humans. Because of the broad range of hosts susceptible to T. gondii, it had been postulated that a universal component of the host cell surface, such as glycosaminoglycans (GAGs), may act as a receptor for T. gondii infection. Carruthers et al. (Infect Immun 68:4005–4011, 2000) showed that soluble GAGs have also been shown to disrupt parasite binding to human fibroblasts. Therefore, we investigated the inhibitory effect of GAGs and their analogue dextran sulfate (DS) on T. gondii infection. For up to 24 h of incubation after inoculation of T. gondii, the inhibitory effect of GAGs on T. gondii infection and growth inside the host cell was weak. In contrast, DS markedly inhibited T. gondii infection. Moreover, low molecular weight DS particularly slowed the growth of T. gondii inside host cells. DS10 (dextran sulfate MW 10 kDa) was the most effective agent in these in vitro experiments and was therefore tested for its inhibitory effects in animal experiments; infection inhibition by DS10 was confirmed under these in vivo conditions. In this report, we showed that DSs, especially DS10, have the potential of a new type of drug for toxoplasmosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Black MW, Boothroyd JC (2000) Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev 64:607–623
Carruthers VB, Håkansson S, Giddings OK, Sibley LD (2000) Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect Immun 68:4005–4011
Dobrowolski JM, Sibley LD (1996) Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 84:933–939
Eustice DC, Feldman PA, Colberg-Poley AM, Buckery RM, Neubauer RH (1991) A sensitive method for the detection of beta-galactosidase in transfected mammalian cells. Biotechniques 11(739–40):742–743
Gong H, Kobayashi K, Sugi T, Takemae H, Kurokawa H, Horimoto T, Akashi H, Kato K (2012) A novel PAN/apple domain-containing protein from Toxoplasma gondii: characterization and receptor identification. PLoS One 7:e30169
Huynh MH, Carruthers VB (2006) Toxoplasma MIC2 is a major determinant of invasion and virulence. PLoS Pathog 2:e84
Jacquet A, Coulon L, De Nève J, Daminet V, Haumont M, Garcia L, Bollen A, Jurado M, Biemans R (2001) The surface antigen SAG3 mediates the attachment of Toxoplasma gondii to cell-surface proteoglycans. Mol Biochem Parasitol 116:35–44
Jones-Brando L, D'Angelo J, Posner GH, Yolken R (2006) In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin. Antimicrob Agents Chemother 50:4216–4218
Katlama C, De Wit S, O'Doherty E, Van Glabeke M, Clumeck NS (1996) Pyrimethamine–clindamycin vs. pyrimethamine–sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 22:268–275
Kitajima S, Takuma S, Morimoto MS (1999) Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis. J Vet Med Sci 61:67–70
Ortega-Barria E, Boothroyd JC (1999) A Toxoplasma lectin-like activity specific for sulfated polysaccharides is involved in host cell infection. J Biol Chem 274:1267–1276
Ortega-Barria E, Pereira ME (1991) A novel T. cruzi heparin-binding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells. Cell 67:411–421
Pancake SJ, Holt GD, Mellouk S, Hoffman SL (1992) Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates. J Cell Biol 117:1351–1357
Reischl U, Bretagne S, Krüger D, Ernault P, Costa JM (2003) Comparison of two DNA targets for the diagnosis of toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis 3:7
Sugi T, Kato K, Kobayashi K, Pandey K, Takemae H, Kurokawa H, Tohya Y, Akashi H (2009) Molecular analyses of Toxoplasma gondii calmodulin-like domain protein kinase isoform 3. Parasitol Int 58:416–423
Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30(12–13):1217–1258
Zhang JP, Stephens RS (1992) Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 69:861–869
Acknowledgments
This study was supported by grant-in-aids for Young Scientists, Exploratory Research, Scientific Research on Innovative Areas (3308) from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan; Bio-oriented Technology Research Advancement Institution (BRAIN); and Program to Disseminate Tenure Tracking System from Japan Science and Technology Agency (JST).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ishiwa, A., Kobayashi, K., Takemae, H. et al. Effects of dextran sulfates on the acute infection and growth stages of Toxoplasma gondii . Parasitol Res 112, 4169–4176 (2013). https://doi.org/10.1007/s00436-013-3608-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-013-3608-8